Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Virios Therapeutics Inc

CUSIP: 92829J954 | 3 institutional holders

Quarters

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile